Obesity Study

Obesity Study

Information About This Study:

A Phase II, randomized, double blind, parallel group, 46 weeks dose-finding study of BI 456906 administered once weekly subcutaneously compared with placebo in patients with obesity or overweight.

Enrolling Now!